Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Colostrinin (CLN), a complex mixture of proline-rich polypeptides derived from colostrums, can alleviate cognitive decline in early Alzheimer's disease patients. The molecular basis of the action of CLN has been studied in vitro using human neuroblastoma cell lines. The aim of the present study was to use quantitative immunocytochemistry and immunoblotting to investigate the ability of CLN to relieve amyloid-beta (Abeta)-induced cytotoxicity in rat primary hippocampal neuronal cells. Our data confirm that CLN alleviates the effect of Abeta-induced cytotoxicity and causes a significant reduction in the elevated levels of the antioxidant enzyme SOD1.

Original publication




Journal article


J Alzheimers Dis

Publication Date





423 - 426


Amyloid beta-Peptides, Animals, Cell Count, Dose-Response Relationship, Drug, Drug Interactions, Embryo, Mammalian, Female, Hippocampus, Male, Nerve Tissue Proteins, Neurons, Organ Culture Techniques, Peptide Fragments, Peptides, Rats, Rats, Sprague-Dawley